Model-based clinical pharmacology profiling of subcutaneous nivolumab in renal cell carcinoma: Bridging to alternative dosing regimens and indications.
- DOI
- 10.1002/cpt.70481
- Published
- 2026 Sep 23
- Container
- Clinical pharmacology and therapeutics
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1002/cpt.70481,
title = {Model-based clinical pharmacology profiling of subcutaneous nivolumab in renal cell carcinoma: Bridging to alternative dosing regimens and indications.},
author = {Zhao Y and Hu Z and Gibson E and Zhu L and Vezina H and Kondic AG},
year = {2026},
journal = {Clinical pharmacology and therapeutics},
doi = {10.1002/cpt.70481},
url = {https://doi.org/10.1002/cpt.70481}
}RIS
TY - JOUR TI - Model-based clinical pharmacology profiling of subcutaneous nivolumab in renal cell carcinoma: Bridging to alternative dosing regimens and indications. AU - Zhao Y AU - Hu Z AU - Gibson E AU - Zhu L AU - Vezina H AU - Kondic AG PY - 2026 JO - Clinical pharmacology and therapeutics DO - 10.1002/cpt.70481 UR - https://doi.org/10.1002/cpt.70481 ER -
APA
Y, Z., Z, H., E, G., L, Z., H, V., & AG, K. (2026). Model-based clinical pharmacology profiling of subcutaneous nivolumab in renal cell carcinoma: Bridging to alternative dosing regimens and indications.. Clinical pharmacology and therapeutics. https://doi.org/10.1002/cpt.70481
Source records
- pubmed · retrieved 2026-09-25T07:11:23.778Z